✦ LIBER ✦

Antithrombin III in children with various renal diseases

✍ Scribed by Hiromu Fukui; Akira Taniguchi; Shinya Sakamoto; Singo Kawahara; Takeshi Matsunaga; Koji Taira; Satoshi Tanaka; Hidekazu Kamitsuji

Publisher: Springer
Year: 1989
Tongue: English
Weight: 640 KB
Volume: 3
Category: Article
ISSN: 0931-041X
DOI: 10.1007/bf00852896

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deficiency of antithrombin III in childr

Deficiency of antithrombin III in children with hemolytic-uremic syndrome

✍ B. Roth; T. Lilien; B. Busch; A. Gillor; M. Bulla 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 458 KB

In nine patients with hemolytic-uremic syndrome, the plasma activity and plasma concentrations of antithrombin III were determined on admission to the hospital and during the clinical course of the disease. Hemodialysis was necessary in six of the patients. In seven children the plasma AT III activi

Recurrent renal vein thrombosis and rena

Recurrent renal vein thrombosis and renal failure associated with antithrombin-III deficiency

✍ Demetrius Ellis 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 841 KB

Low molecular weight proteins in childre

Low molecular weight proteins in children with renal disease

✍ Paul A. Tomlinson 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 871 KB

Prognostication in children with renal d

Prognostication in children with renal disease —with emphasis on IgA nephropathy

✍ Ronald J. Hogg; Richard Browne 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 224 KB

Immune response to influenza vaccination

Immune response to influenza vaccination in children with renal disease

✍ Susan L. Furth; Alicia M. Neu; Susanna A. McColley; Barbara Case; Mark Steinhoff 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 338 KB

Increased antithrombin III concentration

Increased antithrombin III concentration in children with acute lymphatic leukaemia receiving L-asparaginase therapy

✍ O'Meara, Anne ;Daly, Martina ;Hallinan, F. H. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB

Previous reports have observed a fall in antithrombin III (AT III) concentration in patients receiving L-asparaginase as part of acute lymphatic leukaemia (ALL) induction therapy. The aim of this study was to define any qualitative changes in AT III that might arise during the course of L-asparagina